title: The reply.
authors.affiliation: Osaka Prefectural Institute of Public Health, Osaka, Japan.
authors.forename: Takako
authors.initials: T
authors.lastname: Kurata
authors.affiliation: Osaka Prefectural Institute of Public Health, Osaka, Japan.
authors.forename: Daiki
authors.initials: D
authors.lastname: Kanbayashi
authors.affiliation: Osaka Prefectural Institute of Public Health, Osaka, Japan; National Hospital Organization Nagoya Medical Center, Nagoya, Japan.
authors.forename: Jun
authors.initials: J
authors.lastname: Komano
authors.affiliation: Osaka Prefectural Institute of Public Health, Osaka, Japan.
authors.forename: Tesuo
authors.initials: T
authors.lastname: Kase
authors.affiliation: Osaka Prefectural Institute of Public Health, Osaka, Japan.
authors.forename: Kazuo
authors.initials: K
authors.lastname: Takahashi
mesh_terms: D006801:Humans; D008297:Male; D008457:Measles / Q000821:virology*; D008458:Measles Vaccine / Q000009:adverse effects*
chemical_list: D008458:Measles Vaccine